Phreesia (PHR) Return on Sales (2018 - 2026)

Phreesia (PHR) posted Return on Sales of 0.0% for Q2 2026, up 122.04% sequentially from 0.0% in Q1 2026, and little changed YoY from 0.0% in Q2 2025.

Phreesia (PHR) Return on Sales (2018 - 2026) Analysis & Trends

Phreesia has reported Return on Sales for 9 years, with the latest figure at 0.0% in Q2 2026.

Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 0.0% (changed 0.0% YoY) and the FY2026 annual result came in at 0.0%, changed 0.0% from the prior year.
Return on Sales climbed to 0.0% in Q2 2026 per PHR's latest filing, from 0.0% in the prior quarter.
Over five years, Return on Sales peaked at 0.0% in Q4 2025 and troughed at 0.01% in Q2 2022.
A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Sales.
The widest YoY moves for Return on Sales: up 0 bps in 2022, down 1 bps in 2022.
Over 5 years, Return on Sales stood at 0.01% in 2022, then jumped by 37 bps to 0.0% in 2023, then jumped by 61 bps to 0.0% in 2024, then surged by 126 bps to 0.0% in 2025, then slumped by 36 bps to 0.0% in 2026.
According to Business Quant data, Return on Sales over the past three periods registered 0.0%, 0.0%, and 0.0% for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	0.00%
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	0.00%
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	0.00%
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	0.00%
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	0.00%
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	0.00%
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	0.00%
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	0.00%
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	0.00%
10	Phreesia	758.43 Mn	682.03 Mn	113.28 Mn	0.00%

Download Data